Cannabinoid News and Research

Latest Cannabinoid News and Research

Discovery of new urinary biomarkers can boost the surveillance of synthetic drug abuse

A team of researchers from the National University of Singapore has come up with a new solution to boost the surveillance of designer drug abuse.

30 Aug 2021

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Every year there are nearly ten million new cases of dementia globally, of which Alzheimer's Disease (AD) is the most common form, accounting for around 60-70% of cases.

2 Aug 2021

Research finds Cannabis terpenes as a promising new target for pain therapies

When it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an "entourage effect," whereby the pain-relieving effects of the plant as a whole are greater than any of its individual parts.

14 Jul 2021

Purisys Adds ISO Certifications Confirming Its Commitment to Quality and Excellence

Purisys LLC, a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials, today announced that it has obtained two additional global ISO certifications: ISO 17025 (Testing and Calibration Laboratories) and ISO 17034 (Reference Materials Producers).

From Purisys 9 Jul 2021

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Scientists at Indiana University have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly used to treat anxiety and depression and known by the brand name Prozac.

1 Jul 2021

Many people with fibromyalgia substitute CBD for opioids and pain medications, finds study

Fibromyalgia is one of many chronic pain conditions that remains stubbornly difficult to treat.

24 Jun 2021

Understanding the risks and benefits of cannabis use among young patients

In recent years, the use of medical cannabis to treat sick kids is on the rise, although questions remain about the benefits and safety of such treatments.

21 Jun 2021

Tiny capsules containing cannabinoids could help treat neurological disorders

A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer’s disease, multiple sclerosis and traumatic brain injuries in the future.

21 Jun 2021

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

Restek’s new cannabinoid 9-component mix streamlines cannabinoid analyses.

From Restek Corporation 3 Jun 2021

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

20 May 2021

Study sheds light on the ability of CBD to reduce pain

It's been hailed as a wonder drug and it's certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024.

23 Apr 2021

Metabolic testing of COVID-19 patients through skin imprints

There is, therefore, a great need to understand how the illness can be diagnosed using more convenient and inexpensive methods. A new study posted to the medRxiv preprint server reveals the potential role of skin imprints to test for biomarkers that indicate a diagnosis of COVID-19 in a non-invasive way.

22 Apr 2021

Medical cannabis use for severe childhood epilepsy may be linked to early puberty

The use of medical cannabis for severe childhood epilepsy may be linked to early puberty, doctors have warned in the journal BMJ Case Reports after treating a 2 year old boy with the condition

15 Apr 2021

Study identifies a 'window of impairment' caused by cannabis intoxication

A comprehensive analysis of 80 scientific studies has identified a 'window of impairment' of between three and 10 hours caused by moderate to high doses of the intoxicating component of cannabis, tetrahydrocannabinol (THC).

12 Apr 2021

New discovery may prove vital to future research on medical cannabis

Medical cannabis is a subject of much debate. There is still a lot we do not know about cannabis, but researchers from the Department of Neuroscience at the Faculty of Health and Medical Sciences have made a new discovery that may prove vital to future research into and treatment with medical cannabis.

19 Mar 2021

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells.

14 Mar 2021

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.

23 Feb 2021

Cannabinoid News and Research

Latest Cannabinoid News and Research

Discovery of new urinary biomarkers can boost the surveillance of synthetic drug abuse

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Research finds Cannabis terpenes as a promising new target for pain therapies

Purisys Adds ISO Certifications Confirming Its Commitment to Quality and Excellence

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Many people with fibromyalgia substitute CBD for opioids and pain medications, finds study

Understanding the risks and benefits of cannabis use among young patients

Tiny capsules containing cannabinoids could help treat neurological disorders

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

Study sheds light on the ability of CBD to reduce pain

Metabolic testing of COVID-19 patients through skin imprints

Medical cannabis use for severe childhood epilepsy may be linked to early puberty

Study identifies a 'window of impairment' caused by cannabis intoxication

New discovery may prove vital to future research on medical cannabis

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Modified lipids target the body’s endocannabinoid system to regulate pain and inflammation

Challenges of Cannabis Analysis and Impacts on Driving and Public Health

Survey: Half of the people with uncontrolled asthma smoke cannabis

Cannabis Testing & Analysis eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cannabinoid News and Research

Latest Cannabinoid News and Research

Cannabis Testing & Analysis eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in